Learn more →
Back to Expert Scholars
hematopoietic-transplant / hematopoietic-transplantChronic GvHD

Stephanie J. Lee

斯蒂芬妮·李

MD, MPH

🏢Fred Hutchinson Cancer Center(弗雷德·哈钦森癌症中心)🌐USA

Associate Director, Clinical Research Division; Professor, University of Washington临床研究部副主任,华盛顿大学教授

74
h-index
3
Key Papers
3
Awards
3
Key Contributions

👥Biography 个人简介

Stephanie Lee is the world's foremost expert on chronic graft-versus-host disease (cGvHD) and patient-reported outcomes after hematopoietic cell transplantation. She leads the NIH Chronic GvHD Consortium and has transformed cGvHD assessment and treatment through validated measurement tools and landmark multicenter clinical trials.

Share:

🧪Research Fields 研究领域

Chronic GvHD慢性移植物抗宿主病
Patient-Reported Outcomes患者报告结局
HSCT造血干细胞移植
Health-Related Quality of Life健康相关生活质量

🎓Key Contributions 主要贡献

Chronic GvHD Measurement and Classification

Co-led development of the NIH Consensus Criteria for cGvHD diagnosis and staging, now the global standard for clinical trials and clinical practice worldwide.

Patient-Reported Outcomes in Transplant

Developed and validated the Lee Symptom Scale and other PRO instruments capturing the patient experience of cGvHD and transplant recovery.

cGvHD Treatment Trials

Led pivotal multicenter trials of novel cGvHD therapies including ibrutinib and belumosudil, contributing to FDA approvals that changed standard of care.

Representative Works 代表性著作

[1]

NIH Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease

Biology of Blood and Marrow Transplantation (2005)

Landmark consensus establishing standardized cGvHD diagnostic and response criteria used globally in research and practice.

[2]

Ibrutinib for chronic graft-versus-host disease after failure of prior therapy

Blood (2017)

Phase 1b/2 trial supporting FDA approval of ibrutinib as the first targeted agent for cGvHD.

[3]

Development and validation of a scale to measure symptoms of chronic graft-versus-host disease

Biology of Blood and Marrow Transplantation (2002)

Introduced the Lee Symptom Scale, widely used in cGvHD trials as a primary patient-reported endpoint.

🏆Awards & Recognition 奖项与荣誉

🏆E. Donnall Thomas Lectureship, ASTCT
🏆NIH Director's Award
🏆Fred Hutchinson Outstanding Mentor Award

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 斯蒂芬妮·李 的研究动态

Follow Stephanie J. Lee's research updates

留下邮箱,当我们发布与 Stephanie J. Lee(Fred Hutchinson Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment